Biopharmaceutical studies on 2-(aminoethanesulfonylamino)pyridine and related compounds. I. Absorption, excretion, metabolism, and preliminary pharmacological investigation.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001798:Blood Proteins / Q000378:metabolism; D002199:Capillary Permeability / Q000187:drug effects; D004487:Edema / Q000188:drug therapy; D005260:Female; D006937:Hypercholesterolemia / Q000188:drug therapy; D008297:Male; D051379:Mice; D011485:Protein Binding / Q000187:drug effects; D011725:Pyridines / Q000097:blood / Q000494:pharmacology / Q000633:toxicity / Q000652:urine; D011817:Rabbits; D051381:Rats; D013449:Sulfonamides / Q000097:blood / Q000494:pharmacology / Q000633:toxicity / Q000652:urine; D013654:Taurine / Q000097:blood / Q000494:pharmacology / Q000633:toxicity / Q000652:urine
D001798:Blood Proteins; D011725:Pyridines; D013449:Sulfonamides; D013654:Taurine